Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-07-23 00:00:00 ET · period of report 2025-07-21 · accession 0001773751-25-000237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-23 | 2025-07-21 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $49.54 | -125.3K | 92.3K | -58% | -$6.21M |
| DM | 2025-07-23 | 2025-07-21 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +125.3K | 134.0K | +1,450% | +$304.6K |
| DM | 2025-07-23 | 2025-07-21 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -125.3K | 806.4K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-07-21 | S | D | 17,001 | $49.43 | 92,313 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-07-21 | M | A | 50,000 | $2.43 | 142,313 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-07-21 | S | D | 41,667 | $49.56 | 92,313 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.09 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2025-07-21 | M | A | 17,001 | $2.43 | 109,314 | D | — | — | |
| 5 | Common | Class A Common Stock | 2025-07-21 | S | D | 50,000 | $49.60 | 92,313 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.07 - $50.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Class A Common Stock | 2025-07-21 | M | A | 16,667 | $2.43 | 108,980 | D | — | — | |
| 7 | Common | Class A Common Stock | 2025-07-21 | S | D | 16,667 | $49.41 | 92,313 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $49.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Class A Common Stock | 2025-07-21 | M | A | 41,667 | $2.43 | 133,980 | D | — | — | |
| 9 | Derivative | Stock Option (right to buy) | 2025-07-21 | M | D | 50,000 | $0.00 | 756,397 | D | $2.43 · — to 2030-06-16 | 50,000 Class A Common Stock | (F7) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. |
| 10 | Derivative | Stock Option (right to buy) | 2025-07-21 | M | D | 16,667 | $0.00 | 848,064 | D | $2.43 · — to 2030-06-16 | 16,667 Class A Common Stock | (F7) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. |
| 11 | Derivative | Stock Option (right to buy) | 2025-07-21 | M | D | 17,001 | $0.00 | 68,008 | D | $2.43 · — to 2030-06-16 | 17,001 Class A Common Stock | (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |
| 12 | Derivative | Stock Option (right to buy) | 2025-07-21 | M | D | 41,667 | $0.00 | 806,397 | D | $2.43 · — to 2030-06-16 | 41,667 Class A Common Stock | (F7) The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. |